Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?
Statistics in Medicine · 2024
DOI: 10.1002/sim.10067 ↗At a glance
Studienprotokoll in Statistics in Medicine, 2024. Written by Matthew Dodd and 5 co-authors. Institution: Department of Medical Statistics, The London School of Hygiene & Tropical Medicine, London, UK. Major MEDLINE topics: Intention to Treat Analysis, Computer Simulation. Cited 3 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: Wellcome Trust.
Abstract (original language)
Background
Non‐inferiority trials comparing different active drugs are often subject to treatment non‐adherence. Intention‐to‐treat (ITT) and per‐protocol (PP) analyses have been advocated in such studies but are not guaranteed to be unbiased in the presence of differential non‐adherence.
Methods
The REMoxTB trial evaluated two 4‐month experimental regimens compared with a 6‐month control regimen for newly diagnosed drug‐susceptible TB. The primary endpoint was a composite unfavorable outcome of treatment failure or recurrence within 18 months post‐randomization. We conducted a simulation study based on REMoxTB to assess the performance of statistical methods for handling non‐adherence in non‐inferiority trials, including: ITT and PP analyses, adjustment for observed adherence, multiple imputation (MI) of outcomes, inverse‐probability‐of‐treatment weighting (IPTW), and a doubly‐robust (DR) estimator.
Results
When non‐adherence differed between trial arms, ITT, and PP analyses often resulted in non‐trivial bias in the estimated treatment effect, which consequently under‐ or over‐inflated the type I error rate. Adjustment for observed adherence led to similar issues, whereas the MI, IPTW and DR approaches were able to correct bias under most non‐adherence scenarios; they could not always eliminate bias entirely in the presence of unobserved confounding. The IPTW and DR methods were generally unbiased and maintained desired type I error rates and statistical power.
Conclusions
When non‐adherence differs between trial arms, ITT and PP analyses can produce biased estimates of efficacy, potentially leading to the acceptance of inferior treatments or efficacious regimens being missed. IPTW and the DR estimator are relatively straightforward methods to supplement ITT and PP approaches.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Medical Statistics, The London School of Hygiene & Tropical Medicine, London, UK.
- The Medical Research Council Clinical Trials Unit (MRC CTU), UCL, London, UK.
- Department of Infectious Disease Epidemiology, The London School of Hygiene & Tropical Medicine, London, UK.
ORCID profiles: Matthew Dodd, James Carpenter, Jennifer A Thompson, Elizabeth Williamson, Katherine Fielding, Diana Elbourne
Funding
- Wellcome Trust
Cite
APA
Dodd, M., Carpenter, J., Thompson, J. A., Williamson, E., Fielding, K., & Elbourne, D. (2024). Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?. Statistics in Medicine. https://doi.org/10.1002/sim.10067
Vancouver
Dodd M, Carpenter J, Thompson JA, Williamson E, Fielding K, Elbourne D. Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?. Statistics in Medicine. 2024. doi:10.1002/sim.10067
BibTeX
@article{Dodd2024,
author = {Dodd, Matthew and Carpenter, James and Thompson, Jennifer A and Williamson, Elizabeth and Fielding, Katherine and Elbourne, Diana},
title = {Assessing efficacy in non‐inferiority trials with non‐adherence to interventions: Are intention‐to‐treat and per‐protocol analyses fit for purpose?},
journal = {Statistics in Medicine},
year = {2024},
doi = {10.1002/sim.10067}
}
EUVIMED